New antiplatelet agents in ACS - Part I
Session comprising selected EuroPCR 2014 abstract submissions
Presentations available when logged in:
- Upstream prasugrel loading in patients with STEMI referred for primary PCI - Does time matter?
- Impact of new P2Y12 blockers on platelet reactivity and clinical outcomes after ACS: insight from a large single centre registry
- Prasugrel versus Ticagrelor in ACS: a randomised comparison
- Alternative strategies to aspirin and clopidogrel for patients presenting with ACS: a network meta-analysis